<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38928701</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4418</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>18</Day></PubDate></JournalIssue><Title>Diagnostics (Basel, Switzerland)</Title><ISOAbbreviation>Diagnostics (Basel)</ISOAbbreviation></Journal><ArticleTitle>Comparative Analysis of Lymphocyte Populations in Post-COVID-19 Condition and COVID-19 Convalescent Individuals.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1286</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/diagnostics14121286</ELocationID><Abstract><AbstractText>Reduced lymphocyte counts in peripheral blood are one of the most common observations in acute phases of viral infections. Although many studies have already examined the impact of immune (dys)regulation during SARS-CoV-2 infection, there are still uncertainties about the long-term consequences for lymphocyte homeostasis. Furthermore, as persistent cellular aberrations have been described following other viral infections, patients with "Post-COVID-19 Condition" (PCC) may present similarly. In order to investigate cellular changes in the adaptive immune system, we performed a retrospective analysis of flow cytometric data from lymphocyte subpopulations in 106 patients with confirmed SARS-CoV-2 infection who received medical care at our institution. The patients were divided into three groups according to the follow-up date; laboratory analyses of COVID-19 patients were compared with 28 unexposed healthy controls. Regarding B lymphocyte subsets, levels of IgA + CD27+, IgG + CD27+, IgM + CD27- and switched B cells were significantly reduced at the last follow-up compared to unexposed healthy controls (UHC). Of the 106 COVID-19 patients, 56 were clinically classified as featuring PCC. Significant differences between PCC and COVID-19 convalescents compared to UHC were observed in T helper cells and class-switched B cells. However, we did not detect specific or long-lasting immune cellular changes in PCC compared to the non-post-COVID-19 condition.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Berger</LastName><ForeName>Luisa</ForeName><Initials>L</Initials><Identifier Source="ORCID">0009-0003-5881-9000</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases and Tropical Medicine, Hospital St. Georg, 04129 Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolf</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9669-0899</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Hospital St. Georg, 04129 Leipzig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ImmunoDeficiencyCenter Leipzig, Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiency Diseases, Hospital St. Georg, 04139 Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalbitz</LastName><ForeName>Sven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Tropical Medicine, Hospital St. Georg, 04129 Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kellner</LastName><ForeName>Nils</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Tropical Medicine, Hospital St. Georg, 04129 Leipzig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ImmunoDeficiencyCenter Leipzig, Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiency Diseases, Hospital St. Georg, 04139 Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xfc;bbert</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6942-5785</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases and Tropical Medicine, Hospital St. Georg, 04129 Leipzig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Leipzig University Medical Center, 04103 Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borte</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Hospital St. Georg, 04129 Leipzig, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ImmunoDeficiencyCenter Leipzig, Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiency Diseases, Hospital St. Georg, 04139 Leipzig, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>program of Open Access Publishing</GrantID><Agency>University of Leipzig</Agency><Country/></Grant><Grant><GrantID>JMF Leipzig</GrantID><Agency>Jeffrey Modell Foundation for Primary Immunodeficiencies</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Diagnostics (Basel)</MedlineTA><NlmUniqueID>101658402</NlmUniqueID><ISSNLinking>2075-4418</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">immune system</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">lymphocyte subpopulations</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition (PCC)</Keyword><Keyword MajorTopicYN="N">post-acute COVID syndrome</Keyword></KeywordList><CoiStatement>According to the journal&#x2019;s policy, none of the authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38928701</ArticleId><ArticleId IdType="pmc">PMC11202600</ArticleId><ArticleId IdType="doi">10.3390/diagnostics14121286</ArticleId><ArticleId IdType="pii">diagnostics14121286</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization 2023 data.who.int, WHO Coronavirus (COVID-19) Dashboard &gt; Cases [Dashboard]  [(accessed on 11 June 2024)].  Available online:  https://data.who.int/dashboards/covid19/cases%0A%0A.</Citation></Reference><Reference><Citation>Cao X. COVID-19: Immunopathology and its implications for therapy. Nat. Rev. Immunol. 2020;20:269&#x2013;270. doi: 10.1038/s41577-020-0308-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0308-3</ArticleId><ArticleId IdType="pmc">PMC7143200</ArticleId><ArticleId IdType="pubmed">32273594</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan M., Liu Y., Zhou R., Deng X., Li F., Liang K., Shi Y. Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China. Immunology. 2020;160:261&#x2013;268. doi: 10.1111/imm.13223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13223</ArticleId><ArticleId IdType="pmc">PMC7283723</ArticleId><ArticleId IdType="pubmed">32460357</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafarzadeh A., Nemati M., Jafarzadeh S. Contribution of STAT3 to the pathogenesis of COVID-19 Abdollah. Microb. Pathog. 2020;154:104836. doi: 10.1016/j.micpath.2021.104836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2021.104836</ArticleId><ArticleId IdType="pmc">PMC7937040</ArticleId><ArticleId IdType="pubmed">33691172</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#xf1;aloza H.F., Lee J.S., Ray P. Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease. PLoS Pathog. 2021;17:e1009850. doi: 10.1371/journal.ppat.1009850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009850</ArticleId><ArticleId IdType="pmc">PMC8412274</ArticleId><ArticleId IdType="pubmed">34473802</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry B.M., De Oliveira M.H.S., Benoit S., Plebani M., Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): A meta-analysis. Clin. Chem. Lab. Med. 2020;58:1021&#x2013;1028. doi: 10.1515/cclm-2020-0369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2020-0369</ArticleId><ArticleId IdType="pubmed">32286245</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotagiri P., Mescia F., Hanson A.L., Turner L., Bergamaschi L., Pe&#xf1;alver A., Richoz N., Moore S.D., Ortmann B.M., Dunmore B.J., et al. The impact of hypoxia on B cells in COVID-19. eBioMedicine. 2022;77:103878. doi: 10.1016/J.EBIOM.2022.103878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.EBIOM.2022.103878</ArticleId><ArticleId IdType="pmc">PMC8856886</ArticleId><ArticleId IdType="pubmed">35189575</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Y., Liu Y., Cao L., Wang D., Guo M., Jiang A., Guo D., Hu W., Yang J., Tang Z., et al. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerg. Microbes Infect. 2020;9:761&#x2013;770. doi: 10.1080/22221751.2020.1747363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1747363</ArticleId><ArticleId IdType="pmc">PMC7170362</ArticleId><ArticleId IdType="pubmed">32228226</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavakolpour S., Rakhshandehroo T., Wei E.X., Rashidian M. Lymphopenia during the COVID-19 infection: What it shows and what can be learned. Immunol. Lett. 2020;225:31&#x2013;32. doi: 10.1016/j.imlet.2020.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2020.06.013</ArticleId><ArticleId IdType="pmc">PMC7305732</ArticleId><ArticleId IdType="pubmed">32569607</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA Netw. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet. Respir. Med. 2021;9:129. doi: 10.1016/S2213-2600(21)00031-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon Q., Pers J.O., Cornec D., Le Pottier L., Mageed R.A., Hillion S. In-depth characterization of CD24highCD38high transitional human B cells reveals different regulatory profiles. J. Allergy Clin. Immunol. 2016;137:1577&#x2013;1584.e10. doi: 10.1016/j.jaci.2015.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2015.09.014</ArticleId><ArticleId IdType="pubmed">26525227</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancro M.P. Age-Associated B Cells. Annu. Rev. Immunol. 2020;38:315&#x2013;340. doi: 10.1146/annurev-immunol-092419-031130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-092419-031130</ArticleId><ArticleId IdType="pubmed">31986068</ArticleId></ArticleIdList></Reference><Reference><Citation>Koczulla A.R., Ankermann T., Behrends U., Berlit P., B&#xf6;ing S., Brinkmann F., Franke C., Gl&#xf6;ckl R., Gogoll C., Hummel T., et al. S1 Guideline Post-COVID/Long-COVID. Pneumologie. 2021;75:869&#x2013;900. doi: 10.1055/a-1551-9734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1551-9734</ArticleId><ArticleId IdType="pubmed">34474488</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Govender M., Hopkins F.R., G&#xf6;ransson R., Svanberg C., Shankar E.M., Hjorth M., Nilsdotter-Augustinsson &#xc5;., Sj&#xf6;wall J., Nystr&#xf6;m S., Larsson M. T cell perturbations persist for at least 6 months following hospitalization for COVID-19. Front. Immunol. 2022;13:931039. doi: 10.3389/fimmu.2022.931039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.931039</ArticleId><ArticleId IdType="pmc">PMC9393525</ArticleId><ArticleId IdType="pubmed">36003367</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deitchman A.N., Torres L., Iyer N.S., Munter S.E., Nixon C.C., Donatelli J., Thanh C., Takahashi S., Hakim J., et al. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2020;36:109518. doi: 10.1016/j.celrep.2021.109518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109518</ArticleId><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali N. Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19. J. Med. Virol. 2020;92:2409&#x2013;2411. doi: 10.1002/jmv.26097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26097</ArticleId><ArticleId IdType="pmc">PMC7301027</ArticleId><ArticleId IdType="pubmed">32516845</ArticleId></ArticleIdList></Reference><Reference><Citation>Regolo M., Vaccaro M., Sorce A., Stancanelli B., Colaci M., Natoli G., Russo M., Alessandria I., Motta M., Santangelo N., et al. Neutrophil-to-Lymphocyte Ratio (NLR) Is a Promising Predictor of Mortality and Admission to Intensive Care Unit of COVID-19 Patients. J. Clin. Med. 2022;11:2235. doi: 10.3390/jcm11082235.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11082235</ArticleId><ArticleId IdType="pmc">PMC9027549</ArticleId><ArticleId IdType="pubmed">35456328</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Park S.S., Kim T.Y., Lee D.G., Kim D.W. Lymphopenia as a biological predictor of outcomes in COVID-19 patients: A nationwide cohort study. Cancers. 2021;13:471. doi: 10.3390/cancers13030471.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13030471</ArticleId><ArticleId IdType="pmc">PMC7865511</ArticleId><ArticleId IdType="pubmed">33530509</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuwa H.A., Shaw T.N., Knight S.B., Wemyss K., McClure F.A., Pearmain L., Prise I., Jagger C., Morgan D.J., Khan S., et al. Alterations in T and B cell function persist in convalescent COVID-19 patients. Med. 2021;2:720&#x2013;735.e4. doi: 10.1016/j.medj.2021.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2021.03.013</ArticleId><ArticleId IdType="pmc">PMC8011689</ArticleId><ArticleId IdType="pubmed">33821250</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheon I.S., Li C., Son Y.M., Goplen N.P., Wu Y., Cassmann T., Wang Z., Wei X., Tang J., Li Y., et al. Immune signatures underlying post-acute COVID-19 lung sequelae. Sci. Immunol. 2021;6:eabk1741. doi: 10.1126/sciimmunol.abk1741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abk1741</ArticleId><ArticleId IdType="pmc">PMC8763087</ArticleId><ArticleId IdType="pubmed">34591653</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiello A., Farzaneh F., Candore G., Caruso C., Davinelli S., Gambino C.M., Ligotti M.E., Zareian N., Accardi G. Immunosenescence and its hallmarks: How to oppose aging strategically? A review of potential options for therapeutic intervention. Front. Immunol. 2019;10:2247. doi: 10.3389/fimmu.2019.02247.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02247</ArticleId><ArticleId IdType="pmc">PMC6773825</ArticleId><ArticleId IdType="pubmed">31608061</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedroso R., Ventura L.H.A., Torres L., Camatta G.C., Caixeta F., Nascimento L., Mota C., Mendes A.C., Ribeiro F., Guimaraes H.C., et al. COVID-19 Induces Senescence and Exhaustion of T Cells in Patients with Mild/Moderate and Severe Disease During a Seven-Day Interval. medRxiv. 2023 doi: 10.1101/2023.01.16.23284612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.01.16.23284612</ArticleId></ArticleIdList></Reference><Reference><Citation>Wildner N.H., Ahmadi P., Schulte S., Brauneck F., Kohsar M., L&#xfc;tgehetmann M., Beisel C., Addo M.M., Haag F., Schulze zur Wiesch J. B cell analysis in SARS-CoV-2 versus malaria: Increased frequencies of plasmablasts and atypical memory B cells in COVID-19. J. Leukoc. Biol. 2021;109:77&#x2013;90. doi: 10.1002/JLB.5COVA0620-370RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.5COVA0620-370RR</ArticleId><ArticleId IdType="pmc">PMC10016889</ArticleId><ArticleId IdType="pubmed">33617048</ArticleId></ArticleIdList></Reference><Reference><Citation>Gjertsson I., Mcgrath S., Grimstad K., Jonsson C.A., Camponeschi A., Thorarinsdottir K., M&#xe5;rtensson I.L. A close-up on the expanding landscape of CD21-/low B cells in humans. Clin. Exp. Immunol. 2022;210:217&#x2013;229. doi: 10.1093/cei/uxac103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cei/uxac103</ArticleId><ArticleId IdType="pmc">PMC9985162</ArticleId><ArticleId IdType="pubmed">36380692</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan F.J., Hope C.M., Masavuli M.G., Lynn M.A., Mekonnen Z.A., Eng A., Yeow L., Garcia-valtanen P., Al-delfi Z., Gummow J., et al. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med. 2022;20:26. doi: 10.1186/s12916-021-02228-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Dan J.M., Mateus J., Kato Y., Hastie K.M., Yu E.D., Faliti C.E., Grifoni A., Ramirez S.I., Haupt S., Frazier A., et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021;371:eabf4063. doi: 10.1126/science.abf4063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf4063</ArticleId><ArticleId IdType="pmc">PMC7919858</ArticleId><ArticleId IdType="pubmed">33408181</ArticleId></ArticleIdList></Reference><Reference><Citation>Newell K.L., Clemmer D.C., Cox J.B., Kayode Y.I., Zoccoli-Rodriguez V., Taylor H.E., Endy T.P., Wilmore J.R., Winslow G.M. Switched and unswitched memory B cells detected during SARS-CoV-2 convalescence correlate with limited symptom duration. PLoS ONE. 2021;16:e0244855. doi: 10.1371/journal.pone.0244855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0244855</ArticleId><ArticleId IdType="pmc">PMC7843013</ArticleId><ArticleId IdType="pubmed">33507994</ArticleId></ArticleIdList></Reference><Reference><Citation>Yapasert R., Khaw-On P., Banjerdpongchai R. Coronavirus infection-associated cell death signaling and potential therapeutic targets. Molecules. 2021;26:7459. doi: 10.3390/molecules26247459.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26247459</ArticleId><ArticleId IdType="pmc">PMC8706825</ArticleId><ArticleId IdType="pubmed">34946543</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodda L.B. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Elsevier; Amsterdam, The Netherlands: 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7682481</ArticleId><ArticleId IdType="pubmed">33296701</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Zhang Y., Han J., Yang M., Zhu J., Jin T. Transitional B cells involved in autoimmunity and their impact on neuroimmunological diseases. J. Transl. Med. 2020;18:131. doi: 10.1186/s12967-020-02289-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02289-w</ArticleId><ArticleId IdType="pmc">PMC7079408</ArticleId><ArticleId IdType="pubmed">32183811</ArticleId></ArticleIdList></Reference><Reference><Citation>Amanna I.J., Carlson N.E., Slifka M.K. Duration of humoral immunity to common viral and vaccine antigens. N. Engl. J. Med. 2007;357:1903&#x2013;1915. doi: 10.1542/peds.2008-2139LLLL.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2008-2139LLLL</ArticleId><ArticleId IdType="pubmed">17989383</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuri-Cervantes L., Pampena M.B., Meng W., Rosenfeld A.M., Ittner C.A.G., Weisman A.R., Agyekum R.S., Mathew D., Baxter A.E., Vella L.A., et al. Comprehensive mapping of immune perturbations associated with severe COVID-19. Sci. Immunol. 2020;5:eabd7114. doi: 10.1126/sciimmunol.abd7114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abd7114</ArticleId><ArticleId IdType="pmc">PMC7402634</ArticleId><ArticleId IdType="pubmed">32669287</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C., Zhou L., Hu Z., Zhang S., Yang S., Tao Y., Xie C., Ma K., Shang K., Wang W., et al. Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China. Clin. Infect. Dis. 2020;71:762&#x2013;768. doi: 10.2139/ssrn.3541136.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3541136</ArticleId><ArticleId IdType="pmc">PMC7108125</ArticleId><ArticleId IdType="pubmed">32161940</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu F., Chen F., Ou Z., Fan Q., Tan X., Wang Y., Pan Y., Ke B., Li L., Guan Y., et al. A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract. Cell. Mol. Immunol. 2020;17:1119&#x2013;1125. doi: 10.1038/s41423-020-00550-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00550-2</ArticleId><ArticleId IdType="pmc">PMC7546387</ArticleId><ArticleId IdType="pubmed">33037400</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., Wu D., Guo W., Cao Y., Huang D., Wang H., Wang T., Zhang X., Chen H., Yu H., et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Investig. 2020;130:2620&#x2013;2629. doi: 10.1172/JCI137244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI137244</ArticleId><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C., Freitag H., Meyer-Arndt L., Wittke K., Zoller T., Steinbeis F., Haffke M., Rudolf G., Heidecker B., Volk H., et al. Chronic COVID-19 Syndrome and Chronic Fatigue Syndrome (ME/CFS) following the first pandemic wave in Germany&#x2014;A first analysis of a prospective observational study. Nat. Commun. 2022;13:1&#x2013;13. doi: 10.1038/s41467-022-32507-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32507-6</ArticleId><ArticleId IdType="pmc">PMC9426365</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Westermeier F., Nacul L.C., Oltra E., Komaroff A.L., Bateman L. Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? Front. Med. 2021;1:606824. doi: 10.3389/fmed.2020.606824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.606824</ArticleId><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones J.F., Ray C.G., Minnich L.L., Hicks M.J., Kibler R., Lucas D.O. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: Elevated anti-early antigen antibodies. Ann. Intern. Med. 1985;102:1&#x2013;7. doi: 10.7326/0003-4819-102-1-.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-102-1-</ArticleId><ArticleId IdType="pubmed">2578266</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I., Davenport T., Wakefield D., Vollmer-Conna U., Cameron B., Vernon S.D., Reeves W.C., Lloyd A. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study. Br. Med. J. 2006;333:575&#x2013;578. doi: 10.1136/bmj.38933.585764.AE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Mccorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Guntur V.P., Nemkov T., de Boer E., Mohning M.P., Baraghoshi D., Cendali F.I., San-Mill&#xe1;n I., Petrache I., D&#x2019;Alessandro A. Signatures of Mitochondrial Dysfunction and Impaired Fatty Acid Metabolism in Plasma of Patients with Post-Acute Sequelae of COVID-19 (PASC) Metabolites. 2022;12:1026. doi: 10.3390/metabo12111026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12111026</ArticleId><ArticleId IdType="pmc">PMC9699059</ArticleId><ArticleId IdType="pubmed">36355108</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deveau T.M., Munter S.E., Ryder D., Buck A., Beck-Engeser G., Chan F., Lu S., Goldberg S.A., Hoh R., et al. Chronic viral coinfections differentially affect the likelihood of developing long COVID. J. Clin. Investig. 2023;133:e163669. doi: 10.1172/JCI163669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI163669</ArticleId><ArticleId IdType="pmc">PMC9888380</ArticleId><ArticleId IdType="pubmed">36454631</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang S.E., Feng A., Meng W., Apostolidis S.A., Mack E., Artandi M., Barman L., Bennett K., Chakraborty S., Chang I., et al. New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat. Commun. 2021;12:5417. doi: 10.1038/s41467-021-25509-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25509-3</ArticleId><ArticleId IdType="pmc">PMC8440763</ArticleId><ArticleId IdType="pubmed">34521836</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H., Zuo Y., Navaz S., Harbaugh A., Hoy C.K., Gandhi A.A., Sule G., Yalavarthi S., Gockman K., Madison J.A., et al. Endothelial Cell&#x2013;Activating Antibodies in COVID-19. Arthritis Rheumatol. 2022;74:1132&#x2013;1138. doi: 10.1002/art.42094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.42094</ArticleId><ArticleId IdType="pmc">PMC9082472</ArticleId><ArticleId IdType="pubmed">35174669</ArticleId></ArticleIdList></Reference><Reference><Citation>Saichi M., Ladjemi Z., Korniotis S. Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity. Nat. Cell Biol. 2021;23:538&#x2013;551. doi: 10.1038/s41556-021-00681-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-021-00681-2</ArticleId><ArticleId IdType="pubmed">33972731</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>